scholarly journals Clinical, pathological and genetic characteristics of autosomal dominant inherited dynamin 2 centronuclear myopathy

2016 ◽  
Vol 13 (5) ◽  
pp. 4273-4278
Author(s):  
XINHONG LIU ◽  
HUAMIN WU ◽  
JIAN GONG ◽  
TAO WANG ◽  
CHUANZHU YAN
2012 ◽  
Vol 33 (6) ◽  
pp. 949-959 ◽  
Author(s):  
Johann Böhm ◽  
Valérie Biancalana ◽  
Elizabeth T. DeChene ◽  
Marc Bitoun ◽  
Christopher R. Pierson ◽  
...  

2010 ◽  
Vol 41 (01) ◽  
Author(s):  
F Hanisch ◽  
A Dietz ◽  
T Grimm ◽  
M Bitoun ◽  
S Zierz

2015 ◽  
Vol 25 (4) ◽  
pp. 345-348 ◽  
Author(s):  
Olivera Casar-Borota ◽  
Johan Jacobsson ◽  
Rolf Libelius ◽  
Carola Hedberg Oldfors ◽  
Edoardo Malfatti ◽  
...  

2020 ◽  
Vol 133 (24) ◽  
pp. 3023-3024
Author(s):  
Xiao Huang ◽  
Xiang-Yi Liu ◽  
Lu Chen ◽  
A-Ping Sun ◽  
Ying-Shuang Zhang ◽  
...  

2020 ◽  
pp. 6-12
Author(s):  
T.M. Sivtseva ◽  
L.G. Goldfarb ◽  
T.K. Davydova ◽  
N. Sambuugin ◽  
K. Toro ◽  
...  

2019 ◽  
Vol 9 (1) ◽  
Author(s):  
Anaïs Fongy ◽  
Sestina Falcone ◽  
Jeanne Lainé ◽  
Bernard Prudhon ◽  
Aurea Martins-Bach ◽  
...  

2007 ◽  
Vol 17 (9-10) ◽  
pp. 881-882 ◽  
Author(s):  
L. Pirra ◽  
A. Dubrovsky ◽  
M. Bitoun ◽  
P. Guicheney ◽  
N. Romero ◽  
...  

2013 ◽  
Vol 104 (2) ◽  
pp. 618a
Author(s):  
Nicholas G. James ◽  
Michelle A. Digman ◽  
Justin A. Ross ◽  
Barbara Barylko ◽  
Lei Wang ◽  
...  

2012 ◽  
Vol 114 (6) ◽  
pp. 678-683 ◽  
Author(s):  
Madoka Mori-Yoshimura ◽  
Aya Okuma ◽  
Yasushi Oya ◽  
Chieko Fujimura-Kiyono ◽  
Hideto Nakajima ◽  
...  

2019 ◽  
Vol 9 (1) ◽  
Author(s):  
Hyunsuk Kim ◽  
Hayne Cho Park ◽  
Hyunjin Ryu ◽  
Hyunho Kim ◽  
Hyun-Seob Lee ◽  
...  

AbstractAutosomal dominant polycystic kidney disease (ADPKD) is one of the main causes of end-stage renal disease (ESRD). Genetic information is of the utmost importance in understanding pathogenesis of ADPKD. Therefore, this study aimed to demonstrate the genetic characteristics of ADPKD and their effects on renal function in 749 Korean ADPKD subjects from 524 unrelated families. Genetic studies of PKD1/2 were performed using targeted exome sequencing combined with Sanger sequencing in exon 1 of the PKD1 gene and a multiple ligation probe assay. The mutation detection rate was 80.7% (423/524 families, 331 mutations) and 70.7% was novel. PKD1 protein-truncating (PKD1-PT) genotype was associated with younger age at diagnosis, larger kidney volume, lower renal function compared to PKD1 non-truncating and PKD2 genotypes. The PKD1 genotype showed earlier onset of ESRD compared to PKD2 genotype (64.9 vs. 72.9 years old, P < 0.001). In frailty model controlled for age, gender, and familial clustering effect, PKD2 genotype had 0.2 times lower risk for reaching ESRD than PKD1-PT genotype (p = 0.037). In conclusion, our results suggest that genotyping can contribute to selecting rapid progressors for new emerging therapeutic interventions among Koreans.


Sign in / Sign up

Export Citation Format

Share Document